Aspreva Pharmaceuticals Corporation To Present At The Merrill Lynch Global Pharmaceutical, Biotechnology And Medical Devices Conference In New York

VICTORIA, Feb. 1 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation today announced that Noel Hall, President and Co-Founder, will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices conference in New York.

The 15 minute presentation will be followed by a 15 minute question and answer session. Mr. Hall's presentation will take place on Thursday, February 8th at 11:40 am ET at the Grand Hyatt.

A live audio web cast of the presentation will be available to all interested parties through a link posted on Aspreva's website at www.aspreva.com in the Investors section.

About Aspreva Pharmaceuticals

Aspreva is an emerging pharmaceutical company focused on identifying, developing and, upon regulatory approval, commercializing new indications for approved drugs and late stage drug candidates for patients living with less common diseases. Aspreva is listed on the NASDAQ Global Select Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV".

CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com

CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications,Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270, sbaker@aspreva.com